MARKET

ARKG

ARKG

ARK Genomic Revolution ETF
BATS

Real-time Quotes | Provided by Morningstar

76.56
+2.92
+3.97%
After Hours: 76.60 +0.04 +0.05% 18:17 05/14 EDT
OPEN
74.45
PREV CLOSE
73.64
HIGH
77.02
LOW
74.34
VOLUME
3.51M
TURNOVER
--
52 WEEK HIGH
115.15
52 WEEK LOW
41.65
TOTAL ASSET
9.63B
YTD YIELD
73.37%
1D
5D
1M
3M
1Y
5Y
ARK ETFs sit out the market rally; here are the latest buys and sells
While the broader markets rebounded on Thursday, the family of ARK Invest ETFs didn't feel too much of the love.The ARK Space Exploration ETF (ARKX) was the only performer in
Seekingalpha · 15h ago
Eversept Partners, LLC Buys ARK Genomic Revolution ETF, Acceleron Pharma Inc, Community Health ...
GuruFocus News · 1d ago
Rex Capital Advisors, LLC Buys American Well Corp, ARK Genomic Revolution ETF, Fastenal Co, ...
GuruFocus News · 1d ago
Why Cramer Sees Cathie Wood's Top Tech Picks Heading Further Lower
CNBC "Mad Money" host Jim Cramer said Tuesday rising inflation is taking a toll on tech stocks, and tech-heavy investors such as Cathie Wood-led Ark Investment Management LLC could see more pain in the near future.
Benzinga · 1d ago
ARK Invest's Cathie Wood Has Joined Board Of European Crypto Platform
-Bloomberg
Bloomberg · 4d ago
Cathie Wood Says Bill Hwang Provided Seed Funding For Ark ETFs
Cathie Wood, the founder, CEO and CIO of Ark Invest, held discussions with Bill Hwang of Archegos Capital about U.S. stocks and, in particular, the media sector back in 2013. 
Benzinga · 6d ago
Cathie Wood loves ARKs setup in the market
Cathie Wood's flagship fund ARK Innovation (ARKK) closed +1.27% today but has had a tumultuous week. At one point, ARKK was down -12.81% and finished the week -9.45%.In an interview with CNBC, Cathie Wood said:
Seekingalpha · 05/07 20:30
ARK Invest's Cathie Wood Says ARK Has Not Seen A Month Of Redemptions Yet
-CNBC interview
CNBC interview · 05/07 19:34
More
No Data
Learn about the latest financial forecast of ARKG. Analyze the recent business situations of ARK Genomic Revolution ETF through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
Ratings
Date
Period
Agency
Ratings
08/31/2020
3 Year
Morningstar
08/31/2020
5 Year
Morningstar
  • Performance
  • Asset Allocation
  • Dividend History
Period
Return
Rank in Cat
1-Day
-6.5584%
--
1-Week
-3.4866%
--
1-Month
2.4678%
--
3-Month
23.9446%
--
6-Month
65.8488%
--
YTD
73.3671%
--
1-Year
102.6009%
--
3-Year
36.0563%
--
5-Year
25.3333%
--
Since Inception
21.9419%
--
No Data
No Data
  • All
No Data
Profile
Fund Name
ARK Genomic Revolution ETF
Risk
Low risk
Inception Date
2014-10-30
Benchmark
NASDAQ Composite CR
Advisor Company
ARK ETF Trust
Custodian
The Bank of New York Mellon
Manager
Catherine D. Wood